INSIGHTS ON QUALITY CONTROL

• 0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?

  Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.

• Building A Culture Of GxP Excellence In 2026—Veeva Training Solutions Podcast

  Shift from basic compliance to a strategic GxP culture. Explore how intentional, role-specific training and leadership support reduce risks and improve business outcomes in this video.

• Maintaining A State Of Control: EM And DES In Biopharma

  Partner with a proven team to streamline your facility validation and environmental monitoring programs with flexible, cGMP-compliant services and reliable on-site collection.

• Biocatalysis 101: Faster, Greener API Manufacturing

  View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.

• Development To Large-Scale cGMP Production

  7/25/2024

  For manufacturers working with a dry powder medium (DPM), early consultation with a supplier can increase the likelihood of success. Uncover a two-phase scale-up strategy for the production of DPM.

• Understanding cGMPs For Phase 1 Investigational Drugs

  8/15/2025

  Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.

• Aseptic Filling Quality Through Precision

  3/20/2026

  Precise measurement shapes every reliable workcell. Meet Andrew, a specialist who verifies components with micron‑level accuracy, ensuring each piece is built to perform exactly as designed.

• Ensuring Compliance For Virtual And Hybrid Pharmaceutical Companies

  10/16/2025

  Proactive, risk-based oversight must be established to manage outsourced GXP activities. This requires a robust QMS and comprehensive quality agreements to safeguard product quality and data integrity.

• Tackling Residual DNA Testing In Biotherapy Manufacturing

  7/16/2025

  Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.